GlassScriptPhysician profile
Dolores Snell
NPI 1750544466
$1,513.27
in general payments reported to CMS, 2019-2025
22 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $279 · 2023: $399 · 2024: $202 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $279.05 | 2022-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $274.79 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $179.18 | 2021-2025 | Airsupra, Farxiga |
| Pfizer INC. | $133.46 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $120.68 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $83.52 | 2021-2024 | Camzyos |
| Exact Sciences Corporation | $69.50 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $59.78 | 2022-2025 | Veozah |
| Lilly USA, LLC | $52.52 | 2022-2025 | Mounjaro, Zepbound |
| Sanofi Pasteur INC. | $30.61 | 2023 | |
| Becton, Dickinson and Company | $26.43 | 2025 | Bd Onclarity |
| Otsuka America Pharmaceutical, INC. | $23.76 | 2025 | Rexulti |
| Aimmune Therapeutics, INC. | $22.12 | 2025 | Zenpep |
| Mimedx Group, INC. | $20.91 | 2025 | |
| Amarin Pharma, INC. | $20.04 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $19.91 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.73 | 2024 | |
| Allergan, INC. | $17.46 | 2022 | |
| Novo Nordisk INC | $17.15 | 2025 | Wegovy |
| Biohaven Pharmaceuticals, INC. | $15.67 | 2021 | |
| Eisai INC. | $14.13 | 2021 | |
| Dexcom, INC. | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dolores Snell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.